Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 1
1977 1
1981 2
1983 2
1985 1
1986 1
1987 5
1988 3
1989 5
1990 12
1991 14
1992 7
1993 8
1994 9
1995 10
1996 11
1997 7
1998 6
1999 10
2000 8
2001 5
2002 6
2003 6
2004 7
2005 3
2006 4
2007 4
2008 11
2009 8
2010 3
2012 4
2013 4
2014 2
2015 2
2016 3
2017 4
2018 3
2019 5
2020 1
2021 3
Text availability
Article attribute
Article type
Publication date

Search Results

203 results
Results by year
Filters applied: . Clear all
Page 1
Efficacy of Propranolol, Bisoprolol, and Pyridostigmine for Postural Tachycardia Syndrome: a Randomized Clinical Trial.
Moon J, Kim DY, Lee WJ, Lee HS, Lim JA, Kim TJ, Jun JS, Park B, Byun JI, Sunwoo JS, Lee ST, Jung KH, Park KI, Jung KY, Kim M, Lee SK, Chu K. Moon J, et al. Neurotherapeutics. 2018 Jul;15(3):785-795. doi: 10.1007/s13311-018-0612-9. Neurotherapeutics. 2018. PMID: 29500811 Free PMC article. Clinical Trial.
Patients were randomly allocated to 4 treatment groups (Group 1: propranolol; Group 2: bisoprolol; Group 3: propranolol + pyridostigmine; Group 4: bisoprolol + pyridostigmine). The orthostatic intolerance questionnaire (OIQ), Beck depression inventory-II (BDI-II), a …
Patients were randomly allocated to 4 treatment groups (Group 1: propranolol; Group 2: bisoprolol; Group 3: propranolol + pyridostigmine
A six-month randomized controlled trial of exercise and pyridostigmine in the treatment of fibromyalgia.
Jones KD, Burckhardt CS, Deodhar AA, Perrin NA, Hanson GC, Bennett RM. Jones KD, et al. Arthritis Rheum. 2008 Feb;58(2):612-22. doi: 10.1002/art.23203. Arthritis Rheum. 2008. PMID: 18240245 Free PMC article. Clinical Trial.
OBJECTIVE: A subset of fibromyalgia (FM) patients have a dysfunctional hypothalamic-pituitary-insulin-like growth factor 1 (IGF-1) axis, as evidenced by low serum levels of IGF-1 and a reduced growth hormone (GH) response to physiologic stimuli. There is evidence that pyridost
OBJECTIVE: A subset of fibromyalgia (FM) patients have a dysfunctional hypothalamic-pituitary-insulin-like growth factor 1 (IGF-1) axis, as …
Pyridostigmine, diethyltoluamide, permethrin, and stress: a double-blind, randomized, placebo-controlled trial to assess safety.
Roy MJ, Kraus PL, Seegers CA, Young SY, Kamens DR, Law WA, Cherstniakova SA, Chang DN, Cooper JA, Sato PA, Matulich W, Krantz DS, Cantilena LR, Deuster PA. Roy MJ, et al. Mayo Clin Proc. 2006 Oct;81(10):1303-10. doi: 10.4065/81.10.1303. Mayo Clin Proc. 2006. PMID: 17036555 Clinical Trial.
OBJECTIVE: To determine whether short-term human exposure to pyridostigmine bromide, diethyltoluamide, and permethrin, at rest or under stress, adversely affects short-term physical or neurocognitive performance. ...Physical and neurocognitive outcome measures and s …
OBJECTIVE: To determine whether short-term human exposure to pyridostigmine bromide, diethyltoluamide, and permethrin, at rest …
The effect of pyridostigmine on small intestinal bacterial overgrowth (SIBO) and plasma inflammatory biomarkers in HIV-associated autonomic neuropathies.
Robinson-Papp J, Nmashie A, Pedowitz E, George MC, Sharma S, Murray J, Benn EKT, Lawrence SA, Machac J, Heiba S, Kim-Schulze S, Navis A, Roland BC, Morgello S. Robinson-Papp J, et al. J Neurovirol. 2019 Aug;25(4):551-559. doi: 10.1007/s13365-019-00756-9. Epub 2019 May 16. J Neurovirol. 2019. PMID: 31098925 Free PMC article. Clinical Trial.
Thirteen participants (87%) experienced an improvement in SIBO following pyridostigmine treatment; with an average improvement of 50% (p = 0.016). ...TNFalpha and sCD14 levels declined by 12% (p = 0.004) and 19% (p = 0.015), respectively; there was no significant change in …
Thirteen participants (87%) experienced an improvement in SIBO following pyridostigmine treatment; with an average improvement of 50% …
Synergistic Pressor Effect of Atomoxetine and Pyridostigmine in Patients With Neurogenic Orthostatic Hypotension.
Okamoto LE, Shibao CA, Gamboa A, Diedrich A, Raj SR, Black BK, Robertson D, Biaggioni I. Okamoto LE, et al. Hypertension. 2019 Jan;73(1):235-241. doi: 10.1161/HYPERTENSIONAHA.118.11790. Hypertension. 2019. PMID: 30571543 Free PMC article. Clinical Trial.
We tested the hypothesis that pyridostigmine will potentiate the pressor effect of atomoxetine and improve orthostatic tolerance and symptoms in patients with severe autonomic failure. Twelve patients received a single oral dose of either placebo, pyridostigmine 60 …
We tested the hypothesis that pyridostigmine will potentiate the pressor effect of atomoxetine and improve orthostatic tolerance and …
Efficacy of single or combined midodrine and pyridostigmine in orthostatic hypotension.
Byun JI, Moon J, Kim DY, Shin H, Sunwoo JS, Lim JA, Kim TJ, Lee WJ, Lee HS, Jun JS, Park KI, Lee ST, Jung KH, Jung KY, Lee SK, Chu K. Byun JI, et al. Neurology. 2017 Sep 5;89(10):1078-1086. doi: 10.1212/WNL.0000000000004340. Epub 2017 Aug 9. Neurology. 2017. PMID: 28794253 Clinical Trial.
In total, 87 patients with symptomatic neurogenic OH were enrolled and randomized to receive 1 of 3 treatments: midodrine only, pyridostigmine only, or midodrine + pyridostigmine. The patients were followed up at 1 and 3 months after treatment. ...Orthostatic sympto …
In total, 87 patients with symptomatic neurogenic OH were enrolled and randomized to receive 1 of 3 treatments: midodrine only, pyridosti
Pilot study of pyridostigmine in constipated patients with autonomic neuropathy.
Bharucha AE, Low PA, Camilleri M, Burton D, Gehrking TL, Zinsmeister AR. Bharucha AE, et al. Clin Auton Res. 2008 Aug;18(4):194-202. doi: 10.1007/s10286-008-0476-x. Epub 2008 Jul 11. Clin Auton Res. 2008. PMID: 18622640 Free PMC article. Clinical Trial.

The effects of i.v. neostigmine on colonic transit and compliance predicted (P < 0.05) the effects of pyridostigmine on colonic transit. CONCLUSIONS: Pyridostigmine improves colonic transit and symptoms in some patients with autonomic neuropathy and constipation.

The effects of i.v. neostigmine on colonic transit and compliance predicted (P < 0.05) the effects of pyridostigmine on colonic tr

Comparative efficacy of yohimbine against pyridostigmine for the treatment of orthostatic hypotension in autonomic failure.
Shibao C, Okamoto LE, Gamboa A, Yu C, Diedrich A, Raj SR, Robertson D, Biaggioni I. Shibao C, et al. Hypertension. 2010 Nov;56(5):847-51. doi: 10.1161/HYPERTENSIONAHA.110.154898. Epub 2010 Sep 13. Hypertension. 2010. PMID: 20837887 Free PMC article. Clinical Trial.
In a subset of patients we tested the combination of pyridostigmine and yohimbine. Our primary outcome was the change in standing diastolic BP 60 minutes after drug administration from baseline. ...Engaging residual sympathetic tone with yohimbine is a more effective appro …
In a subset of patients we tested the combination of pyridostigmine and yohimbine. Our primary outcome was the change in standing dia …
Neuromuscular blockade reversal with sugammadex versus pyridostigmine/glycopyrrolate in laparoscopic cholecystectomy: a randomized trial of effects on postoperative gastrointestinal motility.
An J, Noh H, Kim E, Lee J, Woo K, Kim H. An J, et al. Korean J Anesthesiol. 2020 Apr;73(2):137-144. doi: 10.4097/kja.19360. Epub 2019 Oct 22. Korean J Anesthesiol. 2020. PMID: 31636242 Free PMC article. Clinical Trial.
BACKGROUND: Acetylcholinesterase inhibitors (e.g., pyridostigmine bromide) are used for neuromuscular blockade (NMB) reversal in patients undergoing surgery under general anesthesia (GA). ...Patients were randomly allocated to the experimental group (sugammadex, Gro …
BACKGROUND: Acetylcholinesterase inhibitors (e.g., pyridostigmine bromide) are used for neuromuscular blockade (NMB) reversal …
Pyridostigmine treatment trial in neurogenic orthostatic hypotension.
Singer W, Sandroni P, Opfer-Gehrking TL, Suarez GA, Klein CM, Hines S, O'Brien PC, Slezak J, Low PA. Singer W, et al. Arch Neurol. 2006 Apr;63(4):513-8. doi: 10.1001/archneur.63.4.noc50340. Epub 2006 Feb 13. Arch Neurol. 2006. PMID: 16476804 Clinical Trial.
OBJECTIVE: To evaluate the efficacy of a single 60-mg dose of pyridostigmine bromide, alone or in combination with a subthreshold (2.5 mg) or suprathreshold (5 mg) dose of midodrine hydrochloride, compared with placebo. ...After 1 day of baseline measurements, patie …
OBJECTIVE: To evaluate the efficacy of a single 60-mg dose of pyridostigmine bromide, alone or in combination with a subthresh …
203 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page